Search Details

Word: eisai (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...According to the pharmaceutical market news service Pharmawire, around $114 billion worth of drugs will go off patent in 2008-12, including lucrative brands such as Eisai's Aricept, which treats Alzheimers, and Pfizer's Lipitor, which lowers cholesterol. Some analysts say patent expirations could lead AstraZeneca and GlaxoSmithKline to lose up to one third of their sales...

Author: /time Magazine | Title: Big Pharma Faces a Crackdown in Europe | 11/28/2008 | See Source »

...runs Ivy Cundill Global Value Fund, is hooked on Nintendo. The maker of Game Boy, says Cundill, has a "pristine balance sheet." among lesser-known stocks is Takeda Chemical, a pharmaceutical maker that "allocates capital intelligently," says David Herro, manager of Oakmark International Fund. Tweedy, Browne's Shrager likes Eisai Co., another drug company, which he reckons is trading 30% to 40% cheaper than the shares of leading U.S. drugmakers...

Author: /time Magazine | Title: Investing: Land of the Rising Stocks | 12/15/2003 | See Source »

...building is being funded by a $8 million gift from Haruo Natio, the chief executive of the Eisai Company, a major Japanese pharmaceutical firm...

Author: By Andrew S. Chang, | Title: Plans Are Underway For 2 New Facilities | 4/25/1997 | See Source »

Kishi has led an Eisai lab in Andover, Mass. since 1980. Reasearch in the lab focuses on developing compounds that may be useful as drugs...

Author: By Ariel R. Frank, | Title: Japanese CEO's $8 Million Gift Funds Building | 3/8/1997 | See Source »

Naito graduated from Keio University and earned his M.B.A. at Northwestern, returning to Japan to join Eisai in 1975, the release said. He has been president and CEO of Esai since...

Author: By Ariel R. Frank, | Title: Japanese CEO's $8 Million Gift Funds Building | 3/8/1997 | See Source »

| 1 | 2 | Next